A supplement manufacturer in Missouri has initiated a voluntary recall of certain batches of its moringa capsules following concerns about potential salmonella contamination.
Mogo Moringa LLC, headquartered in Saint Louis, Missouri, announced on May 25, 2026, that it is pulling specific lots of its Mogo Moringa Capsules from the market as a precautionary measure.
The company’s recall notice was posted on the FDA’s official website for recalls, market withdrawals, and safety alerts.
Salmonella contamination can pose serious health risks to consumers, particularly those with compromised immune systems, young children, and elderly individuals.
Consumers who have purchased the affected product lots are advised to discontinue use and contact the company for further instructions.
